Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Roche new software version (2.7) from this Spring

    Hey all,

    I was wondering how the 2.7 software was received by the sequencing community? We are thinking about installing it pretty soon, but have heard that it was buggy in the early stages and some people were unhappy. Any and all experience with the new software that came out this spring would be much appreciated. Running the GS Junior BTW

  • #2
    I understood it was a GS Junior release only, and wasn't planned as a general release.

    Comment


    • #3
      ...and it would seem I'm the only GSJ user on the forums

      Comment


      • #4
        I don't think they sold many of them. I reckon they would have done a LOT better if the yield was just a bit higher! As it stands, it is just a little bit too low to be useful for bacterial genome assemblies (except for small 1-2Mbp ones).

        Comment


        • #5
          That's true, we only use ours for 16s sequencing and pooled libraries of many samples, but it works well enough for that. I guess I will keep my fingers crossed that the one other user installed the software and reads this!

          Comment


          • #6
            I have the 2.7 software and I'm using it for data analysis. I have a FLX, so the instrument is of course still at 2.6 and I'm waiting for 2.8 for it. I got the 2.7 for data analysis mainly for the changes in the AVA software. I find those changes help me out a lot by getting rid of a lot of the spurious reads instead of making them consensus reads. Otherwise I can't say much about it.

            Comment


            • #7
              Anyone have a copy for the GS Junior Software because my disk was steal it, i will pay for the copies
              Thanks

              Comment

              Latest Articles

              Collapse

              • seqadmin
                Current Approaches to Protein Sequencing
                by seqadmin


                Proteins are often described as the workhorses of the cell, and identifying their sequences is key to understanding their role in biological processes and disease. Currently, the most common technique used to determine protein sequences is mass spectrometry. While still a valuable tool, mass spectrometry faces several limitations and requires a highly experienced scientist familiar with the equipment to operate it. Additionally, other proteomic methods, like affinity assays, are constrained...
                04-04-2024, 04:25 PM
              • seqadmin
                Strategies for Sequencing Challenging Samples
                by seqadmin


                Despite advancements in sequencing platforms and related sample preparation technologies, certain sample types continue to present significant challenges that can compromise sequencing results. Pedro Echave, Senior Manager of the Global Business Segment at Revvity, explained that the success of a sequencing experiment ultimately depends on the amount and integrity of the nucleic acid template (RNA or DNA) obtained from a sample. “The better the quality of the nucleic acid isolated...
                03-22-2024, 06:39 AM

              ad_right_rmr

              Collapse

              News

              Collapse

              Topics Statistics Last Post
              Started by seqadmin, 04-11-2024, 12:08 PM
              0 responses
              27 views
              0 likes
              Last Post seqadmin  
              Started by seqadmin, 04-10-2024, 10:19 PM
              0 responses
              31 views
              0 likes
              Last Post seqadmin  
              Started by seqadmin, 04-10-2024, 09:21 AM
              0 responses
              27 views
              0 likes
              Last Post seqadmin  
              Started by seqadmin, 04-04-2024, 09:00 AM
              0 responses
              52 views
              0 likes
              Last Post seqadmin  
              Working...
              X